Published in: Oncogene vol. 22, no. 41, pp. 6462-6468 (September 25, 2003).
doi:10.1038/sj.onc.1206808
http://www.nature.com/cgi-taf/DynaPage.taf?file=/onc/journal/v22/n41/abs/1206808a.html&dynoptions=doi1064512310

"Hyperexpression of locus C genes in the HOX network is strongly associated in vivo with human bladder transitional cell carcinomas".

Monica Cantile 1, Luca Cindolo 2, Giorgio Napodano 2, Vincenzo Altieri 2, and Clemente Cillo 1

1 Department of Clinical and Experimental Medicine, Federico II University Medical School, Via S. Pansini 5, 80131 Naples, Italy

2 Department of Urology, Federico II University Medical School, Via S. Pansini 5, 80131 Naples, Italy

Correspondence to: C Cillo,     E-mail: clecillo@unina.it



Abstract:

Bladder carcinogenesis remains unclear despite the identification of chemical, environmental and genetic factors. It has recently been reported that the chromosomal region 12q13-q15, containing crucial cancer genes such as MDM2, CDK4 and GLI, is amplified in bladder cancer. In the same region are also located the genes of the locus HOX C, flanked by keratin genes whose protein product may be a prognostic marker of bladder cancer. The HOX genes constitute a network of transcription factors controlling embryonal development and play an important role in crucial adult eukaryotic cell functions. The molecular organization of this 39-gene network is unique in the genome and probably acts by regulating phenotypical cell identity. We have analysed the expression of the whole HOX gene network in pairs of normal-tumour bladder and in tumoral biopsies. Comparison between normal urothelium and bladder tumour has identified dramatic variations of expression in a block of three genes (HOX C4, HOX C5 and HOX C6) localized in the HOX C locus on the chromosome 12q13 and in the paralogous group 11 HOX genes, involved during normal development in the formation of the
urogenital system. These data suggest a key involvement of the HOX gene network, and especially the locus C, in bladder cancer.



Additional References:

1. Ji P, Diederichs S, Wang W, Böing S, Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E, Thomas M, Berdel1 WE, Serve H and Müller-Tidow C, "MALAT-1, a novel noncoding RNA, and thymosin b4 predict metastasis and survival in early-stage non-small cell lung cancer".

2. Luo Y, Kurz J, MacAfee N,  and Krause MO, "C-myc Deregulation during Transformation Induction: Involvement of 7SK RNA".

3. Blume SW, Miller DM, Guarcello V, Shrestha K, Meng Z, Snyder RC, Grizzle WE, Ruppert JM, Gartland GL, Stockard CR, Jones DE, Jr, and Emanuel PD, "Inhibition of tumorigenicity by the 5'-untranslated RNA of the human c-myc P0 transcript".

4. Frenster JH, "Selective Control of DNA Helix Openings during Gene Regulation".

5. Frenster JH, "Nuclear RNA Species Activate DNA Transcription within Chromatin".

6. Gottesfeld JM, and Barbas CF III, "RNA as a Transcriptional Activator".

7. Hovsepian JA, and Frenster JH, "RNA-Induced Melting of DNA during Selective Gene Transcription".

8. Saha S, Ansari AZ, Jarell KA, and Ptashne M, "RNA Sequences that Work as Transcriptional Activating Regions".

9. Frenster JH, "Ultrastructural Probes of Active DNA Sites, and the RNA Activators of DNA".
 



Top of Page - Euchromatin Network - Current Research - Forums - Other Sites - Future Events -

For Further Information or Feedback:
e-mail:   frenster@euchromatin.net
Phone:   +1 650 367 6483
Fax:   +1 650 364 1773

euchromatin:  "the most active portion of the genome within the cell nucleus".